This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Oligosaccharide was liberated by the method of Byers et al. (Byers HL et al. (1999) Glycobiology 9:469-479). Briefly, material was suspended in 0.1ml anhydrous hydrazine and incubated 5 hours at 95 C. Hydrazine was then evaporated under a gentle stream of dry air. Material was subsequently re-N acetylated by resuspending in 0.2ml saturated sodium bicarbonate, adding 10 l of acetic anhydride and incubating 1 hour at room temperature. The reaction mixture was then desalted on a 1ml Dowex H+ column and lyophilized. Oligosaccharides were isolated by method of Shimizu et al. (Shimizu Y et al. (2001) Carbohy. Res. 332:381-388). Briefly, lyophilized material was resuspended in a mixture of butonal:ethanol:water 4:1:1:v:v and loaded on a 1ml column of Avicel PH-101 cellulose which was preequilibrated in the same solvent after wash with 50% ethanol. The column was then eluted with 30ml butanol:ethanol:water 4:1:1, 10ml of 50% ethanol and 10ml of water. Oligosaccharides were noted in only the 50% ethanol eluated which was partially dried under a stream of dry air and lyophilized. Material was suspended in 0.5M dihydroxybenzoic acid in methanol and subjected by MALDI-MS on an Applied Biosystems Voyages DE MS which was run in the positive mode. All masses were calibrated by angiotension and ACTH controls run immediately before the samples.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR018502-04
Application #
7359066
Study Section
Special Emphasis Panel (ZRG1-BECM (40))
Project Start
2006-07-01
Project End
2007-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
4
Fiscal Year
2006
Total Cost
$618
Indirect Cost
Name
University of Georgia
Department
Type
Organized Research Units
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Gas-Pascual, Elisabet; Ichikawa, Hiroshi Travis; Sheikh, Mohammed Osman et al. (2018) CRISPR/Cas9 and glycomics tools for Toxoplasma glycobiology. J Biol Chem :
Sheikh, M Osman; Thieker, David; Chalmers, Gordon et al. (2017) O2 sensing-associated glycosylation exposes the F-box-combining site of the Dictyostelium Skp1 subunit in E3 ubiquitin ligases. J Biol Chem 292:18897-18915
Ma, Liang; Chen, Zehua; Huang, Da Wei et al. (2016) Genome analysis of three Pneumocystis species reveals adaptation mechanisms to life exclusively in mammalian hosts. Nat Commun 7:10740
Dwyer, Chrissa A; Katoh, Toshihiko; Tiemeyer, Michael et al. (2015) Neurons and glia modify receptor protein-tyrosine phosphatase ? (RPTP?)/phosphacan with cell-specific O-mannosyl glycans in the developing brain. J Biol Chem 290:10256-73
Li, Juan; Tao, Shujuan; Orlando, Ron et al. (2015) N-glycosylation profiling of porcine reproductive and respiratory syndrome virus envelope glycoprotein 5. Virology 478:86-98
Karumbaiah, Lohitash; Enam, Syed Faaiz; Brown, Ashley C et al. (2015) Chondroitin Sulfate Glycosaminoglycan Hydrogels Create Endogenous Niches for Neural Stem Cells. Bioconjug Chem 26:2336-49
Li, Juan; Murtaugh, Michael P (2015) Functional analysis of porcine reproductive and respiratory syndrome virus N-glycans in infection of permissive cells. Virology 477:82-8
DePaoli-Roach, Anna A; Contreras, Christopher J; Segvich, Dyann M et al. (2015) Glycogen phosphomonoester distribution in mouse models of the progressive myoclonic epilepsy, Lafora disease. J Biol Chem 290:841-50
Panin, Vladislav M; Wells, Lance (2014) Protein O-mannosylation in metazoan organisms. Curr Protoc Protein Sci 75:Unit 12.12.
Ingale, Jidnyasa; Tran, Karen; Kong, Leopold et al. (2014) Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies. J Virol 88:14002-16

Showing the most recent 10 out of 104 publications